does tricare cover glp 1 for weight loss ending coverage of popular drugs some retirees, other patients Disenrolled From Your TRICARE Plan
Description
The number of participants using sodium-glucose cotransporter-2 (SGLT2) inhibitors was low at baseline (15%), but that number increased during the trial
C., Diz-Chaves, Y., & Mallo, F
2022;36 doi: 10.47176/mjiri.36.39
Image Credit: siamionau pavel / Shutterstock Background Weight loss reduces obesity-related comorbidities but often leads to decreased bone mineral density (BMD) and increased bone turnover, raising fracture risk and mortality
Qiao LY, Goldberg JL, Russell JC, Sun XJ
